FindTrial
Sign In

Compare the Clinical effect of alfentanil and remifentanil in the treatment of uterine fibroids with high -intensity focused ultrasound (HIFU)

Compare the Clinical effect of alfentanil and remifentanil in the treatment of uterine fibroids with high -intensity focused ultrasound (HIFU)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069062
Enrollment
Unknown
Registered
2023-03-06
Start date
2023-03-01
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine fibroids

Interventions

Alfentanil group:alfentanil
Remifentanil group:remifentanil

Sponsors

Chengdu Jinxin obstetrics and Gynecology Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients with uterine leiomyoma treated with high-intensity focused ultrasound in our hospital have uterine leiomyoma = 3cm 2. No recent history of sedative and analgesic drugs 3. Sign informed consent

Exclusion criteria

Exclusion criteria: 1. Patients with severe respiratory insufficiency 2. Patients with cardiac insufficiency and poor control of severe hypertension 3. Kidney or liver disease 4. Obesity (BMI > 35m /kg2) 5. There may be difficult airway 6. Respiratory tract infection within one week

Design outcomes

Primary

MeasureTime frame
Respiratory depression;—

Secondary

MeasureTime frame
bradycardia;hypotension;Nausea and vomiting;Operation duration;—

Countries

China

Contacts

Public ContactJia Fei

Chengdu Jinxin obstetrics and Gynecology Hospital

jiafei1980@sina.com18581877655

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026